Andrea is a Professor of Physiology at the University of Adelaide, South Australia, and a member of the Institute for Photonics and Advanced Sensing. She obtained her PhD in Physiology and Cell Biology from the University of California Santa Barbara, and subsequently worked as a research fellow in Neuropharmacology at Scripps Clinic and Research Foundation in California. After further postdoctoral research in Molecular and Cellular Physiology at Stanford University, she was appointed as an academic staff member in the Dept of Physiology at the University of Arizona, with joint appointments in the Dept of Pharmacology and the Division of Neuroscience. She moved to Australia as Professor and Head of Physiology at the University of Adelaide in 2007. Her goals as director of the Aquaporin Physiology and Drug Discovery Program are to define the molecular basis of the dual water and ion channel function of aquaporins (AQPs), to understand the roles of AQPs in physiological systems, and to build a definitive portfolio of AQP antagonist and agonist compounds as tools for basic research and clinical innovation.
Andrea is a Professor of Physiology at the University of Adelaide, South Australia, and a member of the Institute for Photonics and Advanced Sensing. She obtained her PhD in Physiology and Cell Biology from the University of California Santa Barbara, and subsequently worked as a research fellow in Neuropharmacology at Scripps Clinic and Research Foundation in California. After further postdoctoral research in Molecular and Cellular Physiology at Stanford University, she was appointed as an academic staff member in the Dept of Physiology at the University of Arizona, with joint appointments in the Dept of Pharmacology and the Division of Neuroscience. She moved to Australia as Professor and Head of Physiology at the University of Adelaide in 2007. Her goals as director of the Aquaporin Physiology and Drug Discovery Program are to define the molecular basis of the dual water and ion channel function of aquaporins (AQPs), to understand the roles of AQPs in physiological systems, and to build a definitive portfolio of AQP antagonist and agonist compounds as tools for basic research and clinical innovation.